LJPCライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (16 8月 2022 @ 05:00):

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases...

Stats
本日の出来高	960 928
平均出来高	0
時価総額	0.00
EPS	$0.0766 ( Q2 \| 2022-08-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	47.62 (Sector) 42.63 (Industry) 24.32
ATR14	$0.137 (2.20%)

AADI -1.76%

ABCL 1.83%

ABCM 0.04%

ABEO -2.84%

ABIO -0.28%

ABOS -2.57%

ABSI 0.00%

ABUS -3.28%

ABVX -2.56%

ACAD -1.41%

ACER -17.95%

ACET -3.06%

ACGN 1.29%

ACHL -4.15%

ACHV -0.22%

ACIU -1.03%

ACLX -0.52%

ACRV -2.97%

ACST -1.95%

ACXP 0.36%

ADAG -3.08%

ADAP -2.47%

ADGI 0.87%

ADIL 0.88%

ADMA -2.50%

ADPT 0.74%

ADTX -4.81%

ADVM -2.60%

ADXN -1.60%

AEON -1.08%

AEZS -3.51%

AFMD -0.37%

AGEN -0.30%

AGIO -1.30%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -6.14%

AKRO -2.68%

AKTX 2.44%

AKUS 0.00%

ALBO 0.00%

ALDX -2.25%

ALEC -3.68%

ALGS -3.69%

ALKS -0.25%

ALLK -8.90%

ALLO -5.88%

ALLR -3.37%

ALNA 3.16%

ALNY 0.65%

ALPN 0.02%

ALPX 0.00%

ALRN -2.50%

ALT -9.65%

ALVR -2.67%

ALXN 0.00%

ALXO -9.13%

ALZN -2.05%

AMRN 1.63%

AMTI -3.13%

ANAB 0.13%

ANEB -4.55%

ANGN 0.00%

ANIX 0.00%

ANL -3.22%

ANNX -0.11%

ANPC -3.15%

APGE -1.39%

APGN 8.48%

APGNW 30.65%

APLM 0.66%

APLS -0.57%

APLT -4.96%

APM -1.26%

APOP 0.38%

APRE 2.29%

APTO 3.38%

APTX 3.17%

APVO 0.95%

ARAV -13.39%

ARCT -4.05%

ARDS -14.23%

ARDX -1.83%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.98%

ARTL -3.62%

ARTLW 0.00%

ARVN 3.29%

ARWR -3.12%

ASLN -1.80%

ASMB -1.23%

ASND -2.05%

ATAI -1.11%

ATHA 5.71%

ATHE 1.13%

ATHX -33.50%

ATNF 3.37%

ATOS 5.37%

ATRA -0.12%

ATXI 0.00%

ATXS -0.44%

AUPH -1.38%

AURA 1.03%

AUTL -0.86%

AVBP -1.83%

AVEO 0.00%

AVIR 0.44%

AVRO -1.41%

AVTE -2.78%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -2.06%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.94%

BCAB 4.58%

BCDA -1.55%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.62%

BCRX -0.99%

BCTX 8.34%

BCTXW -16.29%

BCYC 0.17%

BDRX -1.78%

BDTX -1.39%

BEAM -1.15%

BFRA -2.91%

BGNE -2.58%

BIOR -3.24%

BIVI 0.20%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.45%

BLTE -0.62%

BLU 0.03%

BLUE -0.52%

BMEA -7.49%

BMRN -0.65%

BNOX -2.51%

BNTC -2.11%

BNTX -0.94%

BOLD -7.90%

BOLT -0.05%

BPMC -1.23%

BPTH 2.38%

BPTS -13.47%

BRNS 0.37%

BRTX -0.71%

BTAI 10.94%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 5.08%

CABA -2.01%

CADL 1.77%

CALA 0.00%

CALC 0.00%

CALT -0.67%

CAPR -3.64%

CARA 4.02%

CARM 3.44%

CASI -3.72%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.40%

CCCC -2.13%

CCXI 0.00%

CDAK 0.00%

CDIO -6.53%

CDIOW 24.00%

CDMO -1.83%

CDMOP 0.04%

CDT 0.00%

CDTTW -39.60%

CDTX -1.05%

CDXC -1.02%

CDXS 4.48%

CELC -3.24%

CELU -3.33%

CELUW 11.80%

CERC -1.68%

CERE -0.51%

CERO -5.39%

CEROW 0.60%

CFRX -27.95%

CGEM -4.69%

CGEN -1.60%

CGON -0.99%

CGTX -1.14%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -3.23%

CLGN 0.60%

CLLS -4.14%

CLNN 2.42%

CLNNW 0.00%

CLRB 6.69%

CLSD -2.00%

CLSN -0.68%

CLVS 0.00%

CMMB 0.97%

CMND 4.84%

CMPI 0.00%

CMPX -3.32%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.63%

CNCE 0.00%

CNSP -39.19%

CNST 0.00%

CNTA -0.34%

CNTB 2.26%

CNTX -3.65%

COCP -2.78%

COEPW 32.45%

COGT -3.13%

CORT 1.32%

COYA 1.79%

CPRX -0.79%

CRBP -1.89%

CRBU -5.11%

CRDF -1.55%

CRGX -0.44%

CRIS -0.38%

CRNX -4.44%

CRSP -0.27%

CRTX 2.63%

CRVO -0.10%

CRVS 2.80%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -1.65%

CTNM -0.80%

CTXR 6.51%

CUE 5.19%

CVAC 0.82%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 11.25%

CYCCP 5.49%

CYCN 1.50%

CYT -2.27%

CYTK -2.02%

CYTO -2.73%

DARE 3.31%

DAWN -1.27%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 13.27%

DNLI -1.21%

DNTH -6.39%

DOMH -1.58%

DRMA -2.15%

DRMAW -1.25%

DRNA 0.00%

DRTS 4.63%

DRTSW 0.00%

DRUG -7.39%

DSGN -0.60%

DTIL 0.89%

DYAI 4.84%

EARS -1.77%

EDIT -2.82%

EDSA -1.00%

EFTR 8.93%

EFTRW -74.07%

EIGR -9.21%

ELAB -2.01%

ELDN 6.30%

ELEV -4.15%

ELOX 7.69%

ELTX -0.88%

ELVN -5.81%

ELYM -4.60%

ENGN 0.00%

ENGNW 0.12%

ENLV 2.53%

ENOB 1.79%

ENSC 5.77%

ENTA -0.35%

ENTO 1.66%

ENTX -1.10%

ENVB 1.41%

EPIX -0.72%

EPRX -2.97%

EPZM 0.00%

EQ 0.91%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.72%

ERNA -0.96%

ERYP 1.30%

ESLA 4.37%

ESLAW 87.05%

ETNB -2.67%

ETON -0.30%

ETTX 0.00%

EVAX -2.56%

EVGN 0.58%

EVLO 0.00%

EWTX 0.00%

EXAI 0.47%

EXEL -0.45%

EYEG -0.69%

EYEN 4.58%

EYPT 0.12%

FATE -7.39%

FBIO 0.59%

FBIOP 0.32%

FBLG -6.00%

FBRX -6.12%

FDMT -4.09%

FENC -0.81%

FGEN -4.26%

FHTX 0.00%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.38%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.80%

FULC -4.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.01%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.98%

GHRS -3.10%

GLMD 0.50%

GLPG -2.13%

GLSI 3.25%

GLTO -0.18%

GLUE -2.63%

GLYC -14.97%

GMAB -0.27%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.33%

GNPX 6.13%

GNTA 3.94%

GOSS -3.86%

GOVX -10.46%

GOVXW -49.04%

GPCR -4.85%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 3.49%

GRTX 2.12%

GTHX 0.23%

GUTS -5.77%

GXGXW 41.67%

GYRE -0.81%

HALO -1.36%

HARP 0.09%

HCWB -7.81%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX 1.15%

HOOK 2.76%

HOTH -1.68%

HOWL -0.85%

HRMY -0.38%

HRTX 1.15%

HSTO 0.00%

HUMA 0.61%

HUMAW -0.01%

IBRX -5.36%

ICCC 0.22%

ICPT 0.21%

ICU 16.57%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.41%

IFRX 0.00%

IGMS -0.59%

IKNA -1.18%

IKT 1.42%

IMAB -1.16%

IMCR -3.58%

IMGN 0.02%

IMGO 0.00%

IMMP 4.94%

IMMX -3.02%

IMNM -3.12%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX 0.00%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.81%

IMV 0.00%

IMVT -2.27%

INAB 0.56%

INBX -0.27%

INCY -1.22%

INDP 10.20%

INFI -52.38%

INKT 0.01%

INM -2.03%

INMB 0.70%

INO -3.75%

INSM -1.10%

INTS -1.47%

INVA 0.12%

INZY 0.69%

IOBT -8.86%

IONS -0.19%

IOVA -1.83%

IPA -0.27%

IPHA 5.58%

IPSC -0.59%

IRON -3.10%

ISEE 0.38%

ITOS -1.16%

ITRM 0.83%

IVA 6.96%

IVVD -1.24%

JAGX 0.19%

JANX -3.67%

JAZZ -1.19%

JNCE 0.00%

JSPR -6.15%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -5.34%

KALV -1.34%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -4.43%

KPRX -0.47%

KPTI 0.46%

KRBP -10.00%

KRON 1.06%

KROS -1.27%

KRRO -3.11%

KRTX 0.03%

KRYS -0.99%

KTRA 10.72%

KTTA 8.16%

KTTAW 0.92%

KURA -1.81%

KYMR -2.99%

KYTX -6.33%

KZIA 7.66%

KZR -0.21%

LABP 0.57%

LBPH -1.23%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.64%

LENZ -4.55%

LEXX -1.15%

LEXXW -14.63%

LGND -0.82%

LGNDV 0.00%

LGVN -8.52%

LIAN -8.28%

LIFE 2.70%

LIPO -6.55%

LIXT -3.77%

LIXTW 95.35%

LJPC -0.32%

LMNL 0.12%

LOGC 0.35%

LPCN -5.27%

LPTX -0.55%

LQDA -0.65%

LRMR -1.64%

LSTA -4.93%

LTRN 1.00%

LUMO -1.32%

LVTX -2.25%

LXEO -3.52%

LXRX -2.93%

LYEL -31.45%

LYRA -1.63%

MACK 0.10%

MBIO -10.13%

MBRX -0.71%

MCRB 6.70%

MDGL -2.58%

MDNA -13.16%

MDWD -0.34%

MDXG -2.36%

MEIP 0.24%

MESO -2.23%

MGNX -4.66%

MGTA -7.74%

MGTX -1.24%

MGX 1.07%

MIRM -1.75%

MIRO 0.59%

MIST 1.53%

MITO 0.00%

MLEC -5.13%

MLECW 2.31%

MLND -5.36%

MLTX -1.32%

MLYS -1.40%

MNKD -1.51%

MNMD -0.39%

MNOV 1.41%

MNPR -4.79%

MOLN -1.65%

MOR 1.06%

MORF -3.16%

MREO -3.43%

MRKR 4.50%

MRNA -4.94%

MRNS -3.31%

MRSN -2.14%

MRTX -0.17%

MRUS -0.18%

MRVI 0.58%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 2.70%

NAMS 0.66%

NAMSW 0.43%

NAUT 1.99%

NBRV 0.71%

NBSE -1.56%

NBTX 8.03%

NCNA 1.32%

NERV -3.48%

NEXI 2.60%

NGM -1.28%

NGNE -0.68%

NKGN 3.36%

NKGNW 8.00%

NKTR -2.80%

NKTX -3.67%

NLSP -4.39%

NLSPW 26.67%

NMRA -0.23%

NMTR -42.97%

NOVN -24.84%

NRBO 11.97%

NRIX 0.29%

NRSN -9.64%

NRSNW 0.00%

NRXP -8.97%

NRXPW 14.03%

NRXS -4.23%

NTBL 5.04%

NTEC -12.45%

NTHI 0.00%

NTLA -7.62%

NTRBW -31.07%

NUVL -1.43%

NVAX -2.86%

NVCT 0.07%

NVIV -34.28%

NXTC -3.82%

NYMX -0.05%

OABI 1.06%

OABIW -10.06%

OBIO -1.46%

OBSV 0.00%

OCEA -0.70%

OCGN 3.81%

OCS -1.02%

OCUL -3.89%

OCUP 1.95%

ODT -4.27%

OKYO 1.51%

OLMA -4.00%

OMER -2.44%

OMGA 3.77%

ONCO 9.54%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 0.74%

ORGS -0.09%

ORIC -3.86%

ORMP 15.04%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.70%

OYST 0.00%

PALI -0.87%

PASG 4.17%

PBLA -7.50%

PBM -4.13%

PBYI -0.51%

PCSA 1.83%

PCVX -0.26%

PDSB 2.53%

PEPG 2.98%

PGEN -2.10%

PHAR 1.51%

PHAS 0.00%

PHAT -2.37%

PHIO -4.96%

PHIOW 36.47%

PHVS -6.38%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.28%

PLUR 4.35%

PMN 0.00%

PMVP -0.60%

PNT 0.16%

PPBT -2.13%

PRAX 1.60%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 1.12%

PRQR 1.77%

PRTA -3.49%

PRTC -0.08%

PRTG 1.95%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -7.65%

PSTX -0.39%

PTCT -1.59%

PTE -0.82%

PTGX -2.49%

PTIXW -5.10%

PULM 2.63%

PXMD 0.00%

PYPD 0.07%

PYXS -0.33%

QLGN 0.00%

QNCX 3.56%

QNRX 0.33%

QSI -11.11%

QSIAW -3.13%

QTTB -5.96%

QURE -1.12%

RAIN -1.63%

RANI 5.08%

RAPT -3.86%

RARE 1.76%

RCKT -5.32%

REGN -1.32%

RENB -4.00%

REPL -1.36%

RETA 0.02%

REUN -0.89%

REVB -6.05%

REVBU 3.46%

REVBW -18.13%

RGLS -3.28%

RGNX -4.63%

RIGL -1.12%

RLAY -4.31%

RLMD 0.67%

RLYB 0.34%

RNA -1.81%

RNAC -4.85%

RNAZ 1.92%

RNXT 4.79%

ROIV -1.48%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.26%

RPTX -2.64%

RUBY 2.70%

RVLP -32.05%

RVMD -0.95%

RVMDW 5.10%

RVNC 0.85%

RVPH 0.25%

RVPHW 1.62%

RXDX 0.09%

RXRX -2.77%

RYTM -4.77%

RYZB 0.02%

RZLT 1.03%

SABS 0.00%

SABSW -11.81%

SAGE 0.28%

SANA -4.52%

SAVA -0.49%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 7.09%

SCPH -0.13%

SCPS 0.00%

SEEL -2.95%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.94%

SGMT 0.12%

SGTX -2.56%

SIOX 22.63%

SLDB -4.91%

SLGL 2.97%

SLN -3.78%

SLNO -2.70%

SLRX 7.29%

SLS -1.96%

SMMT 0.37%

SNDX -0.97%

SNGX 1.70%

SNPX -0.32%

SONN 0.00%

SPPI -0.49%

SPRB 0.91%

SPRC -1.98%

SPRO 0.23%

SRNE -25.00%

SRPT -1.42%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -3.51%

STRO -4.17%

STSA 0.00%

STTK -4.64%

SURF -0.93%

SVRA 1.31%

SWTX -0.27%

SYBX 0.00%

SYRS -1.72%

TALS -0.73%

TARA -7.62%

TARS -1.12%

TBPH 0.42%

TCBP 1.37%

TCDA 0.00%

TCON -3.38%

TCRR 0.00%

TCRT 2.64%

TCRX 1.46%

TECH -0.06%

TENX -1.27%

TERN -4.55%

TFFP -3.52%

TGTX -2.61%

THRX 0.12%

TIL 0.02%

TLC 0.00%

TLSA -2.07%

TNGX 0.38%

TNXP -2.40%

TNYA -5.43%

TPST 0.03%

TRDA -2.71%

TRVI -1.53%

TRVN 1.00%

TSHA -19.88%

TSVT -3.46%

TTNP -4.07%

TVTX -0.38%

TYRA -5.24%

UBX -0.48%

UNCY -3.72%

URGN -3.07%

UTHR -0.38%

VACC 11.36%

VALN -2.68%

VAXX 171.43%

VBIV 0.76%

VBLT -8.77%

VCEL -0.53%

VCNX 9.01%

VCYT -0.62%

VERA -2.64%

VERU 0.72%

VERV -2.77%

VIGL 3.63%

VINC 1.74%

VIR 0.00%

VIRI -3.21%

VIRX 3.24%

VKTX -0.59%

VLON -13.04%

VNDA -1.55%

VOR -3.63%

VRCA -0.36%

VRDN -4.54%

VRNA -0.47%

VRPX 0.40%

VRTX 0.53%

VSTM -3.23%

VTGN -1.20%

VTVT -6.43%

VTYX -2.51%

VXRT -0.01%

VYGR -1.60%

VYNE -3.15%

VYNT 7.78%

WINT -3.24%

WVE -3.98%

XBIO 0.97%

XBIT -2.29%

XCUR 6.28%

XENE -2.08%

XERS 1.19%

XFOR 3.03%

XLO 4.43%

XLRN 0.00%

XNCR -0.26%

XOMA -1.45%

XOMAO 0.36%

XOMAP -0.82%

XRTX -7.04%

YMAB -2.28%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.94%

ZNTL -3.81%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-08-22	Rosen Robert	Sell	30 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	18 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 11 680 911

ボリューム相関

長: 0.33 (neutral)

短: -0.74 (moderate negative)

Signal:(78.937) Neutral

La Jolla Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

La Jolla Pharmaceutical 相関 - 通貨/商品

0.29
( neutral )

-0.63
( weak negative )

0.77
( moderate )

0.37
( neutral )

-0.47
( neutral )

-0.54
( weak negative )

La Jolla Pharmaceutical 財務諸表

Annual	2021
収益:	$75.72M
総利益:	$62.23M (82.19 %)
EPS:	$0.720

FY	2021
収益:	$75.72M
総利益:	$62.23M (82.19 %)
EPS:	$0.720

FY	2020
収益:	$33.42M
総利益:	$25.60M (76.60 %)
EPS:	$-1.440

FY	2019
収益:	$23.05M
総利益:	$20.66M (89.62 %)
EPS:	$-4.30

Financial Reports:

No articles found.

La Jolla Pharmaceutical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

La Jolla Pharmaceutical

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.